Auksė Mickienė

Auksė Mickienė

Auto-generated profile, based on publicly available information

Auksė Mickienė

Lithuanian University of Health Sciences, Department of Infectious Disease, Kaunas Clinical Hospital, Baltijos str. 120, LT-47116 Kaunas, Lithuania

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Vaccine
Verified
Journal Article
Closed access
GGGiedre Gefenaite
Giedre Gefenaite
JRJanette Rahamat-Langendoen
Janette Rahamat-Langendoen
AAArvydas Ambrozaitis
Arvydas Ambrozaitis
AMAukse Mickiene
Aukse Mickiene
LJLigita Jancoriene
Ligita Jancoriene
EHEelko Hak
Eelko Hak

11 January 2011 in Medicina
Verified
Journal Article
Open access
AMAuksė Mickienė
Auksė Mickienė
LDLina Daniusevičiūtė
Lina Daniusevičiūtė
NVNeringa Vanagaitė
Neringa Vanagaitė
DVDaiva Vėlyvytė
Daiva Vėlyvytė
OBOna Blauzdžiūnienė
Ona Blauzdžiūnienė
LJLiucija Jodžiūnienė
Liucija Jodžiūnienė
The objective of this study was to identify case characteristics and clinical course of the disease in patients hospitalized with 2009 pandemic influenza A (H1N1) infection during the first wave of the pandemic and to identify risk factors associated with the complicated course of illness. Material and methods. A retrospective study of adult cases of the laboratory-confirmed 2009 pandemic influenza A (H1N1) virus admitted to three hospitals in Kaunas between November 1, 2009, and March 15, 2010, was carried out. The main outcome measures were clinical characteristics, risk factors for complicated disease, treatment, and clinical course of the disease. Results. The study enrolled 121 of the 125 patients hospitalized due to 2009 pandemic influenza A (H1N1) virus infection. The median age was 31 years (range, 18–83); 5% of the patients were aged more than 65 years. Pregnant and postpartum women comprised 26% of all hospitalized cases. Nearly half (49.5%) of those who underwent chest radiography had findings consistent with pneumonia, which was bilateral in one-third of cases. The risk to have pandemic influenza complicated by pneumonia increased significantly with one-day delay from symptom onset to antiviral treatment (OR, 2.241; 95% CI, 1.354–3.710). More than half (57%) of the patients received antiviral treatment. In 45% of the treated patients, antiviral drugs were administered within 48 hours from symptom onset. Intensive care was required in 7.4% of the cases. The overall mortality was 5% (6/121). The median age of the patients who died was 43.5 years (range, 23–62); 4 patients had been previously healthy, 1 patient suffered from chronic lympholeukemia, and 1 patient was a pregnant woman. Conclusion. The 2009 pandemic influenza A (H1N1) caused considerable morbidity in a significant proportion of hospitalized adults. The main risk factor associated with the complicated course of illness was delayed antiviral treatment.

11 November 2009 in Medicina
Verified
Journal Article
Open access
PDF file
LDLina Dvaranauskaitė
Lina Dvaranauskaitė
DVDaiva Vėlyvytė
Daiva Vėlyvytė
VKVirginija Kurklietytė
Virginija Kurklietytė
AGAntanas Gumbelevičius
Antanas Gumbelevičius
EKEvaldas Keleras
Evaldas Keleras
AMAuksė Mickienė
Auksė Mickienė
This article presents a clinical case of late diagnosis of cerebral toxoplasmosis and cytomegalovirus retinitis of right eye in a 32-year-old patient who was unaware of her HIV status. In addition, this article reviews the literature reflecting clinical, diagnostic, and treatment issues of some opportunistic infections in AIDS.